Journal
AMERICAN JOURNAL OF PSYCHIATRY
Volume 163, Issue 9, Pages 1594-1602Publisher
AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.163.9.1594
Keywords
-
Categories
Ask authors/readers for more resources
Objective: Several antidepressants raise striatal dopamine, but the role of striatal dopamine during major depressive episodes is unclear. Striatal [C-11] raclopride binding potential measured with positron emission tomography is an index of D-2 type receptors and is sensitive to extracellular dopamine levels (higher D-2 binding potential occurs when dopamine is lower). It was hypothesized that putamen D-2 binding potential would be higher during major depressive episodes featuring motor retardation. Method: Drug-free, nonsmoking subjects experiencing a major depressive episode (N=21) underwent [C-11] raclopride PET imaging as did 21 healthy age-matched comparison subjects. Motor retardation was measured with the finger tapping test. Results: The depressed subjects exhibiting motor retardation had significantly higher D-2 binding potential in both the left and right putamen than did healthy subjects, and putamen D-2 binding potential correlated significantly with motor speed in the depressed subjects. Conclusions: The results argue that extracellular dopamine is lower in subjects experiencing a major depressive episode that features motor retardation. This depression subtype should preferentially benefit from dopamine-increasing medications and should be targeted in future clinical trials of dopamine reuptake inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available